Related Experiment Video
Updated: Mar 19, 2026
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Evidence of alterations in brain structure and antioxidant status following 'low-dose' monosodium glutamate ingestion
Olakunle James Onaolapo1, Adejoke Yetunde Onaolapo2, M A Akanmu3
1Department of Pharmacology, Faculty of Basic Medical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Osun State, Nigeria; Department of Pharmacology, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Objective:
The study investigated the effects of low dose monosodium glutamate (MSG) on the brain, with a view to providing information on its effects on neuronal morphology and antioxidant status in mice.
Methodology:
Sixty male mice (20-22 g) were divided into six groups of ten animals each. Vehicle (distilled water), a standard (l-glutamate at 10mg/kg body weight) or MSG (10, 20, 40 and 80mg/kg body weight) were administered orally for 28days. Sections of the cerebrum, hippocampus and cerebellum were processed and stained using hematoxylin and eosin, examined under a microscope and captured images analysed. Plasma and brain levels of glutamate, glutamine, and antioxidants were assayed. Data obtained were analysed using descriptive and inferential statistics.
Results:
MSG ingestion did not significantly alter body weight. Relative brain weight increased at 40 and 80mg/kg compared to vehicle. Histological and histomorphometric changes consistent with neuronal damage were seen in the cerebrum, hippocampus and cerebellum at 40 and 80mg/kg. Plasma glutamate and glutamine assay showed significant increase at 40 and 80mg/kg while no significant difference in total brain glutamate or glutamine levels were seen. Levels of brain superoxide dismutase and catalase decreased with increasing doses of MSG, while nitric oxide (NO) increased at these doses.
Conclusion:
The study showed morphological alterations consistent with neuronal injury, biochemical changes of oxidative stress and a rise in plasma glutamate and glutamine. These data therefore still support the need for cautious consideration in the indiscriminate use of MSG as a dietary flavor enhancer.
